Skip to main content

Table 1 Demographic characteristics of the UHH cohort (n = 82)

From: Pirfenidone improves survival in IPF: results from a real-life study

Age

74.9 ± 11a

 Never smokers

29 (35.3%)

 Smokers

53 (64.7%)

Pack Years

43.5 ± 32.1a

Radiological pattern (Definite UIP/Possible UIP)

47(57.3%)/35(42.7%)

Advanced disease (DLco< 30%)

7(8.5%)

Surgical lung biopsy

13 (15.9%)

FEV1%

87.4 ± 22.7a

FVC %

81.5 ± 19.5a

DLco %

54.4 ± 17.9a

Median follow-up time (IQR)

17.4 months (9.5–30.9).

Deaths

15 (18.3%)

  1. UIP usual interstitial pneumonia, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, DLco diffusing capacity of the lung for carbon monoxide
  2. aThe values are expressed as mean ± SD